Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Tedeschini, Y. Levkovitz, N. Iovieno, Victoria Ameral, J. Nelson, G. Papakostas (2011)
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.The Journal of clinical psychiatry, 72 12
P. Jensen, L. Arnold, J. Severe, B. Vitiello, K. Hoagwood, S. Hinshaw, G. Elliott, C. Conners, K. Wells, J. March, J. Swanson, D. Cantwell, T. Wigal, H. Abikoff, J. Hechtman, Ll Greeenhill, J. Newcorn, W. Pelham, B. Hoza, H. Kraemer, R. Gibbons, E. Schiller (2004)
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.Pediatrics, 113 4
Abigail Taylor, S. Deb, G. Unwin (2011)
Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review.Research in developmental disabilities, 32 3
S. Mannuzza, R. Klein, J. Moulton (2008)
Lifetime criminality among boys with attention deficit hyperactivity disorder: A prospective follow-up study into adulthood using official arrest recordsPsychiatry Research, 160
N. Maneeton, B. Maneeton, S. Suttajit, J. Reungyos, M. Srisurapanont, S. Martin (2014)
Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHDDrug Design, Development and Therapy, 8
T. Spencer, J. Biederman, T. Wilens, R. Doyle, Craig Surman, J. Prince, E. Mick, Megan Aleardi, Kathleen Herzig, S. Faraone (2005)
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBiological Psychiatry, 57
J. Undurraga, R. Baldessarini (2012)
Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic ReviewNeuropsychopharmacology, 37
J. Biederman, C. Petty, K. Woodworth, A. Lomedico, Laran Hyder, S. Faraone (2012)
Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study.The Journal of clinical psychiatry, 73 7
R. Weisler, G. Pandina, E. Daly, K. Cooper, C. Gassmann-Mayer (2012)
Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity DisorderCNS Drugs, 26
Marc Stone, T. Laughren, M. Jones, Mark Levenson, P. Holland, Alice Hughes, T. Hammad, R. Temple, George Rochester (2009)
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationThe BMJ, 339
JM Bae (2014)
Meta-epidemiologyEpidemiol Health, 25
P. Hazell, Shuyu Zhang, T. Wolańczyk, J. Barton, Mats Johnson, A. Zuddas, M. Danckaerts, A. Ladikos, D. Benn, R. Yoran-Hegesh, P. Zeiner, D. Michelson (2006)
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorderEuropean Child & Adolescent Psychiatry, 15
M. Seixas, M. Weiss, U. Müller (2012)
Systematic review of national and international guidelines on attention-deficit hyperactivity disorderJournal of Psychopharmacology, 26
P. Asherson, C. Bushe, K. Saylor, Y. Tanaka, W. Deberdt, H. Upadhyaya (2014)
Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trialsJournal of Psychopharmacology (Oxford, England), 28
X. Castells, J. Ramos-Quiroga, D. Rigau, R. Bosch, M. Nogueira, X. Vidal, M. Casas (2011)
Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity DisorderCNS Drugs, 25
S. Dalsgaard, S. Østergaard, J. Leckman, P. Mortensen, M. Pedersen (2015)
Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort studyThe Lancet, 385
A. Dechartres, I. Boutron, L. Trinquart, Pierre Charles, P. Ravaud (2011)
Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic StudyAnnals of Internal Medicine, 155
K. Peterson, M. McDonagh, R. Fu (2008)
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysisPsychopharmacology, 197
T. Stroup, J. McEvoy, M. Swartz, M. Byerly, I. Glick, J. Cañive, M. McGee, G. Simpson, M. Stevens, J. Lieberman (2003)
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.Schizophrenia bulletin, 29 1
F. Levin, S. Evans, D. Brooks, Aparna Kalbag, F. Garawi, E. Nunes (2006)
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.Drug and alcohol dependence, 81 2
J. Biederman, S. Faraone, T. Spencer, E. Mick, M. Monuteaux, Megan Aleardi (2006)
Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community.The Journal of clinical psychiatry, 67 4
C. Pérez-Mañá, X. Castells, M. Torrens, D. Capellà, M. Farré (2013)
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.The Cochrane database of systematic reviews, 9
J Cohen (1988)
Statistical power analysis in the behavioural sciences
M. Weiss, K. Gadow, M. Wasdell (2006)
Effectiveness outcomes in attention-deficit/hyperactivity disorder.The Journal of clinical psychiatry, 67 Suppl 8
E. Willcutt (2012)
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic ReviewNeurotherapeutics, 9
C. Berkey, D. Hoaglin, F. Mosteller, G. Colditz (1995)
A random-effects regression model for meta-analysis.Statistics in medicine, 14 4
S. Kooij, S. Bejerot, A. Blackwell, H. Caci, M. Casas-Brugué, P. Carpentier, D. Edvinsson, J. Fayyad, K. Foeken, M. Fitzgerald, V. Gaillac, Y. Ginsberg, C. Henry, J. Krause, M. Lensing, I. Manor, H. Niederhofer, Carlos Nunes-Filipe, M. Ohlmeier, P. Oswald, S. Pallanti, A. Pehlivanidis, J. Ramos-Quiroga, M. Råstam, Doris Ryffel-Rawak, S. Stes, P. Asherson (2010)
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry, 10
L. Jerome, A. Segal, Liat Habinski (2006)
What we know about ADHD and driving risk: a literature review, meta-analysis and critique.Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 15 3
X Castells, JA Ramos-Quiroga, D Rigau, R Bosch, M Nogueira, X Vidal, M Casas (2011)
Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysisCNS Drugs, 25
V. Simon, P. Czobor, S. Bálint, Á. Mészáros, I. Bitter (2009)
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysisBritish Journal of Psychiatry, 194
G. Polanczyk, G. Salum, L. Sugaya, A. Caye, L. Rohde (2015)
Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents.Journal of child psychology and psychiatry, and allied disciplines, 56 3
C. Begg, Madhuchhanda Mazumdar (1994)
Operating characteristics of a rank correlation test for publication bias.Biometrics, 50 4
H. Peyre, N. Hoertel, F. Limosin, C. Dubuc, Paris Cité (2014)
15. CADDRA. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). 3rd ed. Toronto, ON: Canadian ADHD Practice Guidelines; 2011.
J. Sharf, L. Primavera, Marc Diener (2010)
Dropout and therapeutic alliance: a meta-analysis of adult individual psychotherapy.Psychotherapy, 47 4
R. Kessler (2006)
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.The American journal of psychiatry, 163 4
J. Bae (2014)
Methodological issues for determining intervals of subsequent cancer screeningEpidemiology and Health, 36
N. Maneeton, B. Maneeton, M. Srisurapanont, S. Martin (2011)
Bupropion for adults with attention‐deficit hyperactivity disorder: Meta‐analysis of randomized, placebo‐controlled trialsPsychiatry and Clinical Neurosciences, 65
S. Schwartz, C. Correll (2014)
Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression.Journal of the American Academy of Child and Adolescent Psychiatry, 53 2
F. Levin, S. Evans, D. Brooks, F. Garawi (2007)
Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.Drug and alcohol dependence, 87 1
B. Bolea-Alamañac, D. Nutt, M. Adamou, P. Asherson, S. Bazire, D. Coghill, D. Heal, U. Müller, J. Nash, P. Santosh, K. Sayal, E. Sonuga-Barke, S. Young (2014)
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 28
R. Cunill, X. Castells, A. Tobías, D. Capellà (2015)
Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependenceJournal of Psychopharmacology, 29
M. Koesters, T. Becker, R. Kilian, J. Fegert, Stefan Weinmann (2009)
Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorderJournal of Psychopharmacology, 23
W. Cochran (1954)
The combination of estimates from different experiments.Biometrics, 10
T. Epstein, N. Patsopoulos, M. Weiser (2014)
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.The Cochrane database of systematic reviews, 9
R. Klein, S. Mannuzza, M. Olazagasti, Erica Roizen, Jesse Hutchison, Erin Lashua, F. Castellanos (2012)
Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later.Archives of general psychiatry, 69 12
J. Newcorn, C. Kratochvil, A. Allen, C. Casat, D. Ruff, Rodney Moore, D. Michelson (2008)
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.The American journal of psychiatry, 165 6
J. Swanson, Suneel Gupta, D. Guinta, D. Flynn, D. Agler, M. Lerner, Lillie Williams, I. Shoulson, S. Wigal (1999)
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in childrenClinical Pharmacology & Therapeutics, 66
M. Weiss, L. Hechtman (2006)
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.The Journal of clinical psychiatry, 67 4
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)
Measuring inconsistency in meta-analysesBMJ : British Medical Journal, 327
Pharmacological treatment provides mild symptom improvement but is associated with frequent AEs and higher treatment discontinuation than placebo, particularly when no concomitant psychotherapy is administered. Stimulants appear more efficacious than non-stimulant drugs and the former should be preferred over the latter. The efficacy of pharmacological treatment should be monitored over time because it may decrease progressively.
Psychopharmacology – Springer Journals
Published: Jan 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.